当前位置: 首页 > 期刊 > 《中国当代医药》 > 2014年第13期
编号:13129203
TAC方案治疗晚期乳腺癌的效果观察(1)
http://www.100md.com 2014年5月5日 吴金辉
第1页

    参见附件。

     [摘要] 目的 观察并分析TAC方案治疗晚期乳腺癌的效果。 方法 随机选择2008年1月~2013年12月在本院就诊的58例乳腺癌患者,随机分为对照组和研究组,每组各29例,对照组行CAF方案,研究组行TAC方案,比较分析两组患者的近期疗效与化疗后毒副反应情况。 结果 化疗后,研究组腋淋巴结阳性近期疗效为68.42%,对照组腋淋巴结阳性近期疗效为50.00%,研究组明显优于对照组,差异有统计学意义(P<0.05)。 结论 CAF方案治疗晚期乳腺癌腋淋巴结阴性患者具有化疗后毒副作用小、疗效确切的特点,TAC方案治疗晚期乳腺癌腋淋巴结阳性患者具有疗效显著、毒副反应耐受性良好的优势。

    [关键词] TAC方案;晚期乳腺癌;疗效

    [中图分类号] R737.9[文献标识码] A[文章编号] 1674-4721(2014)05(a)-0066-03

    Clinical observation of TAC regimen in treatment of advanced breast cancer

    WU Jin-hui

    Oncology Department,People′s Hospital of Yucheng City in Shandong Province,Yucheng 251200,China

    [Abstract] Objective To observe and analyze the effect of TAC regimen in treatment of advanced breast cancer. Methods 58 patients with breast cancer were randomly selected in our hospital from January 2008 to December 2013,they were randomly divided into control group and study group,each group of 29 cases,the control group was teated with CAF scheme,and the study group was treated with TAC scheme,the curative effect and toxic and side reaction after chemotherapy of two groups were compared and analyzed ......

您现在查看是摘要介绍页,详见PDF附件